← Leaderboards
Kathleen Redington
Georgetown University
$27,193
Attributed
$27,193
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9.9K · FY2005–08$10K$7.5K$5K$2.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$27,193 · 6
By mechanism
M01$27,193 · 6
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- G. William Rebeck$14,030,662
- Carol A Colton$13,242,597
- Alan Ira Faden$23,991,268
- Jeanne Mandelblatt$29,742,067
- Mark P Burns$8,120,799
Others in their field
Top investigators on “Simvastatin”
- Ronald M Krauss · University Of Calif-Lawrenc Berkeley Lab$25,216,704
- Ruth M McBride · Axio Research, Llc$15,107,487
- Marisa Wong Medina · Children'S Hospital & Res Ctr At Oakland$7,421,968
- Petros C Karakousis · Johns Hopkins University$6,496,565
- Bruce G Brown · University Of Washington$5,814,431
- Robert David Steiner · Oregon Health And Science University$5,252,429
Research focus
SimvastatinAlzheimer&AposGuidelinesInstitutionLipidsOutcome MeasurePharmaceutical PreparationsPlacebo ControlPlacebosRandomizedResearch PersonnelResourcesSafetyS DiseaseSiteSourceUnited States National Institutes Of HealthWeekComputer Retrieval Of Information On Scientific Projects DatabaseDesignDouble-Blind MethodEnrollmentFundingGrant
Grant awards (6)
CLINICAL TRIAL: A MULTI-CENTER TRIAL OF SIMVASTATIN TO SLOW THE PROGRESSION OF A$2,140
M01 · FY2008 · RR · contact PI
A MULTI-CENTER TRIAL OF SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S DI$7,083
M01 · FY2007 · RR · contact PI
A MULTI-CENTER TRIAL OF SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S DI$2,860
M01 · FY2007 · RR · contact PI
A MULTI-CENTER TRIAL OF SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S DI$4,646
M01 · FY2006 · RR · contact PI
SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S DISEASE$9,061
M01 · FY2005 · RR
Simvastatin to slow the progression of alzheimer's disease$1,403
M01 · FY2004 · RR